Global Myocardial Infarction Drug Market Research Report 2019

Table of Contents

Executive Summary

1 Myocardial Infarction Drug Market Overview

• 1.1 Product Overview and Scope of Myocardial Infarction Drug
• 1.2 Myocardial Infarction Drug Segment by Type
  • 1.2.1 Global Myocardial Infarction Drug Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 JVS-200
  • 1.2.3 KR-33028
  • 1.2.4 AMRS-001
  • 1.2.5 ANG-4011
  • 1.2.6 Balixafortide
  • 1.2.7 CAP-1002
  • 1.2.8 Cenderitide
  • 1.2.9 Others
• 1.3 Myocardial Infarction Drug Segment by Application
  • 1.3.1 Myocardial Infarction Drug Consumption Comparison by Application (2014-2025)
  • 1.3.2 Research Center
  • 1.3.3 Hospital
  • 1.3.4 Clinic
• 1.3 Global Myocardial Infarction Drug Market by Region
  • 1.3.1 Global Myocardial Infarction Drug Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Myocardial Infarction Drug Market Size
  • 1.4.1 Global Myocardial Infarction Drug Revenue (2014-2025)
  • 1.4.2 Global Myocardial Infarction Drug Production (2014-2025)

2 Global Myocardial Infarction Drug Market Competition by Manufacturers

• 2.1 Global Myocardial Infarction Drug Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Myocardial Infarction Drug Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Myocardial Infarction Drug Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Myocardial Infarction Drug Production Sites, Area Served, Product Types
• 2.5 Myocardial Infarction Drug Market Competitive Situation and Trends
  • 2.5.1 Myocardial Infarction Drug Market Concentration Rate
  • 2.5.2 Myocardial Infarction Drug Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Myocardial Infarction Drug Production Market Share by Regions

• 3.1 Global Myocardial Infarction Drug Production Market Share by Regions
• 3.2 Global Myocardial Infarction Drug Revenue Market Share by Regions (2014-2019)
• 3.3 Global Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Myocardial Infarction Drug Production
  • 3.4.1 North America Myocardial Infarction Drug Production Growth Rate (2014-2019)
  • 3.4.2 North America Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Myocardial Infarction Drug Production
  • 3.5.1 Europe Myocardial Infarction Drug Production Growth Rate (2014-2019)
  • 3.5.2 Europe Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Myocardial Infarction Drug Production (2014-2019)
  • 3.6.1 China Myocardial Infarction Drug Production Growth Rate (2014-2019)
  • 3.6.2 China Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Myocardial Infarction Drug Production (2014-2019)
  • 3.7.1 Japan Myocardial Infarction Drug Production Growth Rate (2014-2019)
  • 3.7.2 Japan Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Myocardial Infarction Drug Consumption by Regions

• 4.1 Global Myocardial Infarction Drug Consumption by Regions
• 4.2 North America Myocardial Infarction Drug Consumption (2014-2019)
• 4.3 Europe Myocardial Infarction Drug Consumption (2014-2019)
• 4.4 China Myocardial Infarction Drug Consumption (2014-2019)
• 4.5 Japan Myocardial Infarction Drug Consumption (2014-2019)

5 Global Myocardial Infarction Drug Production, Revenue, Price Trend by Type

• 5.1 Global Myocardial Infarction Drug Production Market Share by Type (2014-2019)
• 5.2 Global Myocardial Infarction Drug Revenue Market Share by Type (2014-2019)
• 5.3 Global Myocardial Infarction Drug Price by Type (2014-2019)
• 5.4 Global Myocardial Infarction Drug Production Growth by Type (2014-2019)

6 Global Myocardial Infarction Drug Market Analysis by Applications

• 6.1 Global Myocardial Infarction Drug Consumption Market Share by Application (2014-2019)
• 6.2 Global Myocardial Infarction Drug Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Myocardial Infarction Drug Business

• 7.1 BioCardia, Inc.
  • 7.1.1 BioCardia, Inc. Myocardial Infarction Drug Production Sites and Area Served
  • 7.1.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.1.3 BioCardia, Inc. Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Biscayne Pharmaceuticals, Inc.
  • 7.2.1 Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production Sites and Area Served
  • 7.2.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.2.3 Biscayne Pharmaceuticals, Inc. Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Capricor Therapeutics, Inc.
  • 7.3.1 Capricor Therapeutics, Inc. Myocardial Infarction Drug Production Sites and Area Served
  • 7.3.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.3.3 Capricor Therapeutics, Inc. Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 CellProthera
  • 7.4.1 CellProthera Myocardial Infarction Drug Production Sites and Area Served
  • 7.4.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.4.3 CellProthera Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Celyad SA
  • 7.5.1 Celyad SA Myocardial Infarction Drug Production Sites and Area Served
  • 7.5.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.5.3 Celyad SA Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Compugen Ltd.
  • 7.6.1 Compugen Ltd. Myocardial Infarction Drug Production Sites and Area Served
  • 7.6.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.6.3 Compugen Ltd. Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 CSL Limited
  • 7.7.1 CSL Limited Myocardial Infarction Drug Production Sites and Area Served
  • 7.7.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.7.3 CSL Limited Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Cynata Therapeutics Limited
  • 7.8.1 Cynata Therapeutics Limited Myocardial Infarction Drug Production Sites and Area Served
  • 7.8.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.8.3 Cynata Therapeutics Limited Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 FibroGen, Inc.
  • 7.9.1 FibroGen, Inc. Myocardial Infarction Drug Production Sites and Area Served
  • 7.9.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.9.3 FibroGen, Inc. Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Hemostemix Ltd
  • 7.10.1 Hemostemix Ltd Myocardial Infarction Drug Production Sites and Area Served
  • 7.10.2 Myocardial Infarction Drug Product Introduction, Application and Specification
  • 7.10.3 Hemostemix Ltd Myocardial Infarction Drug Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Human Stem Cells Institute
• 7.12 HUYA Bioscience International, LLC
• 7.13 Immune Pharmaceuticals Inc.
• 7.14 Juventas Therapeutics, Inc.
• 7.15 Laboratoires Pierre Fabre SA
• 7.16 Lee's Pharmaceutical Holdings Limited
• 7.17 LegoChem Biosciences, Inc

8 Myocardial Infarction Drug Manufacturing Cost Analysis

• 8.1 Myocardial Infarction Drug Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Myocardial Infarction Drug
• 8.4 Myocardial Infarction Drug Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Myocardial Infarction Drug Distributors List
• 9.3 Myocardial Infarction Drug Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Myocardial Infarction Drug Market Forecast

• 11.1 Global Myocardial Infarction Drug Production, Revenue Forecast
  • 11.1.1 Global Myocardial Infarction Drug Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Myocardial Infarction Drug Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Myocardial Infarction Drug Price and Trend Forecast (2019-2025)
• 11.2 Global Myocardial Infarction Drug Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Myocardial Infarction Drug Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Myocardial Infarction Drug Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Myocardial Infarction Drug Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Myocardial Infarction Drug Production, Revenue Forecast (2019-2025)
• 11.3 Global Myocardial Infarction Drug Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Myocardial Infarction Drug Consumption Forecast (2019-2025)
  • 11.3.2 Europe Myocardial Infarction Drug Consumption Forecast (2019-2025)
  • 11.3.3 China Myocardial Infarction Drug Consumption Forecast (2019-2025)
  • 11.3.4 Japan Myocardial Infarction Drug Consumption Forecast (2019-2025)
• 11.4 Global Myocardial Infarction Drug Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Myocardial Infarction Drug Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List